Evidence map›Paper›PMID 38849841›Full record

ArticleJournal of nanobiotechnology2024

NIR triggered polydopamine coated cerium dioxide nanozyme for ameliorating acute lung injury via enhanced ROS scavenging.

Mingjing Yin, Doudou Lei, Yalan Liu, Tao Qin, Huyang Gao, Wenquan Lv, Qianyue Liu, Lian Qin, Weiqian Jin, Yin Chen and 5 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Biological Applications of Functionalized Cerium Oxide Nanoparticles.International journal of medical sciences · 2026
    Review
  16. Review
  17. [Antibacterial properties, biocompatibility, and clinical selection strategies of root canal filling materials for primary teeth].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mingjing YinIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Doudou LeiIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Yalan LiuIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Tao QinDepartment of Intensive Care Unit, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
Huyang GaoLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Wenquan LvDepartment of Emergency, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, Nanning, Guangxi, 530022, China.
Qianyue LiuLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Lian QinIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Weiqian JinLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Yin ChenIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Hao LiangCollege & Hospital of Stomatology, Guangxi Medical University, Nanning, Guangxi, 530021, China.
Bailei WangIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.
Ming GaoLife Sciences Institute, Guangxi Medical University, Nanning, Guangxi, 530021, China. gaoming1983125@hotmail.com.
Jianfeng ZhangIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China. zhangjianfeng@gxmu.edu.cn.
Junyu LuIntensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China. junyulu@gxmu.edu.cn.

Funding

2023 Basic Ability Improvement Project for Young and Middle-Aged Teachers in Colleges and Universities in Guangxi 2023KY0117High-level Medical Expert Training Program of Guangxi "139" Plan Funding G202003010Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation 2023GXNSFDA026023Key Research & Development Program of Guangxi GuiKeAB22080088Medical Appropriate Technology Development and Popularization and Application Project of Guangxi S2020099National Natural Science Foundation of China 82060022National Natural Science Foundation of China 82360372Natural Science Foundation of Guangxi 2023JJA140322
6 · The paper itself

Abstract

Acute lung injury (ALI) is a life threatening disease in critically ill patients, and characterized by excessive reactive oxygen species (ROS) and inflammatory factors levels in the lung. Multiple evidences suggest that nanozyme with diversified catalytic capabilities plays a vital role in this fatal lung injury. At present, we developed a novel class of polydopamine (PDA) coated cerium dioxide (CeO

Indexed as

Acute Lung InjuryCeriumIndolesPolymersReactive Oxygen SpeciesAnimalsAnti-Inflammatory AgentsAntioxidantsCytokinesFree Radical ScavengersInfrared RaysLipopolysaccharidesLungMacrophagesMaleMiceAnti-Inflammatory AgentsAntioxidantsceric oxideCeriumCytokinesFree Radical ScavengersIndolesLipopolysaccharidespolydopaminePolymersReactive Oxygen SpeciesAcute lung injuryM2 directional polarizationNanozymeROS scavengingSynergistic enhanced therapy

Identifiers

PMID38849841
PMCPMC11162040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.